Filter
Period
Filter by
recent search
Showing: 1 – 05 of 114 Regulated Information
–
05 September 2023
05 September 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 35 – 2023
Aggregated presentation by day and by market
–
04 September 2023
04 September 2023
Ipsen nominates Pascal Touchon to its Board of Directors as new independent director
PARIS, FRANCE, 4 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today the co-optation of Pascal Touchon to its Board as an independent director, effective 4 October 2023, following the decision of Paul Sekhri to step down from his director…
–
01 September 2023
01 September 2023
Ipsen announces change in R&D leadership: Howard Mayer to retire, succeeded by Christelle Huguet
PARIS, FRANCE, 1 September 2023 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Christelle Huguet as Executive Vice President, Head of Research and Development. She will succeed Howard Mayer, EVP and Head…
–
29 August 2023
29 August 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 34 – 2023
Aggregated presentation by day and by market
–
22 August 2023
22 August 2023
IPSEN – Buy-back programme – Art 5 of MAR – Week 33 – 2023
Aggregated presentation by day and by market